Impact of the Manchester Glaucoma Enhanced Referral Scheme on NHS costs.
glaucoma
Journal
BMJ open ophthalmology
ISSN: 2397-3269
Titre abrégé: BMJ Open Ophthalmol
Pays: England
ID NLM: 101714806
Informations de publication
Date de publication:
2019
2019
Historique:
received:
21
01
2019
revised:
23
07
2019
accepted:
23
08
2019
entrez:
2
11
2019
pubmed:
2
11
2019
medline:
2
11
2019
Statut:
epublish
Résumé
Glaucoma filtering schemes such as the Manchester Glaucoma Enhanced Referral Scheme (GERS) aim to reduce the number of false positive cases referred to Hospital Eye Services. Such schemes can also have wider system benefits, as they may reduce waiting times for other patients. However, previous studies of the cost consequences and wider system benefits of glaucoma filtering schemes are inconclusive. We investigate the cost consequences of the Manchester GERS. Observational study. A cost analysis from the perspective of the National Health Service (NHS) was conducted using audit data from the Manchester GERS. 2405 patients passed through the Manchester GERS from April 2013 to November 2016. 53.3% were not referred on to Manchester Royal Eye Hospital (MREH). Assuming an average of 2.3 outpatient visits to MREH were avoided for each filtered patient, the scheme saved the NHS approximately £2.76 per patient passing through the scheme. Our results indicate that glaucoma filtering schemes have the potential to reduce false positive referrals and costs to the NHS.
Identifiants
pubmed: 31673631
doi: 10.1136/bmjophth-2019-000278
pii: bmjophth-2019-000278
pmc: PMC6797377
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e000278Informations de copyright
© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
Eye (Lond). 2003 Jan;17(1):21-6
pubmed: 12579165
Health Econ. 2016 Aug;25(8):955-68
pubmed: 26013773
Ophthalmic Physiol Opt. 2011 Jan;31(1):23-8
pubmed: 21070302
Ophthalmic Physiol Opt. 2013 Mar;33(2):183-9
pubmed: 23406492
Eye (Lond). 2011 Jan;25(1):43-9
pubmed: 20966973
Br J Ophthalmol. 2019 Aug;103(8):1066-1071
pubmed: 30309913
Ophthalmic Physiol Opt. 2011 Jul;31(4):339-42
pubmed: 21545475
Ophthalmic Physiol Opt. 2011 Jul;31(4):343-52
pubmed: 21615447
Ophthalmology. 2014 Nov;121(11):2081-90
pubmed: 24974815
Clin Exp Ophthalmol. 2012 May-Jun;40(4):e163-70
pubmed: 21883774
BMJ Open. 2013 Jul 21;3(7):null
pubmed: 23878172
Br J Ophthalmol. 2005 Sep;89(9):1102-4
pubmed: 16113358
Health Technol Assess. 2007 Oct;11(41):iii-iv, ix-x, 1-190
pubmed: 17927922